Insights

  • Date

  • Content Type

  • Reset

Article

Science and Tech Innovation Drive Promise of Therapeutic Cancer Vaccines

6.06.23

By Daina Vanags, Cori Gorman & Christian K Schneider

Advances in immunotherapy treatments, starting ..
Read More

Blog

How our vaccines team supports innovation across global healthcare systems

8.11.22

By Michael Pfleiderer, PhD

Development of vaccines is a complex, evolving and highly specialized field that spans innovation, regulatory
Read More

Article

Overcoming challenges for personalized cancer vaccines

11.04.22

By Ilona Baraniak and Aleksandra Nevmerzhitskaya

Advances in the field of personalized cancer vaccines create potential for more targeted, less toxic
Read More

Article

Designing Vaccines: The Role of Artificial Intelligence and Digital Health, Part 2

16.12.21
By Aleksandra Nevmerzhitskaya

In BPI’s October 2021 issue, part one of this review introduced the concepts of machine learning (ML)...
Read More

Article

Designing Vaccines: The Role of Artificial Intelligence and Digital Health, Part 1

9.11.21
By Aleksandra Nevmerzhitskaya

According to the founder and executive chairman of the World Economic Forum, Klaus Schwab
Read More

Blog

Better late than never? What developers of SARS-CoV-2 vaccines in early-to -late-stage development should consider

12.05.21

By Michael Pfleiderer

Unfortunately, as of today the ongoing pandemic is still far from being under control, with close to 3...

Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more